Abstract: The present invention relates to a novel transgenic plant having tolerance to salt stress. The plant is transformed with a recombinant nucleic acid encoding glutamic acid decarboxylase isolated from Oryza sativa. Still further it also relates to a method of producing the transgenic plants that are salt tolerant.

Abstract: A process is described for producing hydrogen comprising producing an aqueous feed stream comprising 5% to 15% wt. ethanol by a biomass fermentation process; separating at least a portion of the water from the feed stream so that the concentration of ethanol in the resulting reformer feed stream is in the range of from 15% to 35% wt.; and contacting the reformer feed stream with a catalyst in a reformer under reforming conditions to produce a reformer product stream comprising hydrogen wherein the pressure in the reformer is in a range of from 100 psi to 600 psi.

Abstract: A process is described for producing hydrogen comprising producing an aqueous feed stream comprising 5% to 15% wt. ethanol by a biomass fermentation process; and contacting the reformer feed stream with a hydrocarbon stream and a catalyst in a reformer under reforming conditions to produce a reformer product stream comprising hydrogen.

Abstract: A seal assembly comprising a first movable stator member movable between a sealing position and a non-sealing position, a second fixed stator member, the first stator member being movable relative to the second stator member, the seal assembly further comprising at least one flexure member coupled to the second stator member, and at least one biasing member coupled between the at least one flexure and the movable stator for biasing the movable stator to a non-sealing position.

Abstract: Novel spatially-defined macrocyclic compounds containing specific conformational control elements are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor.

Abstract: A system (160) and method (400) is provided for validating a location of a tracking device. The method can include monitoring (902) a set of signal strengths (600) to one or more personal area networks (104) and one or more cellular towers (110), generating (906) a Radio Frequency Time Profile RFTP (700) from the set of signal strengths, comparing (908) the RFTP o coverage variation limits (720) of one or more pre-calibrated paths, and signaling (910) an alert if the set of signal strengths are not within the coverage variation limit of the one or more pre-calibrated paths. The RFTP is a time series of the signal strengths between the tracking device and the one or more PANs resulting from a change in location of the tracking device.

Abstract: A method for use in operating a plurality of wind turbines is provided. An aggregate noise level at one or more geographic positions is calculated. The aggregate noise level is compared to a target noise level associated with the geographic position. When the aggregate noise level differs substantially from the target noise level, an operational adjustment is transmitted to at least one wind turbine controller. When the aggregate noise level is greater than the target noise level, such an operational adjustment may lead to a decrease in the aggregate noise level. Conversely, when the aggregate noise level is less than the target noise level, such an operational adjustment may lead to an increase in the aggregate noise level, facilitating an increase in the overall power output of the wind turbines.

Abstract: Poly(vinyl ester) block copolymers comprising blocks of two or more different vinyl ester repeating units. The vinyl ester repeating units may be wherein R is H, C1-C22 straight or branched alkyl or alkylhalide, or phenyl or substituted phenyl, and n is 10 to 12,000. Methods of making poly(vinyl ester) block copolymers, including reversible-addition fragmentation chain transfer, organobismuthine-mediated living radical polymerization, and cobalt mediated radical polymerization. Chemically-degradable and biodegradable polymers comprising poly(vinyl ester) block copolymers.

Abstract: A method for use in calculating a possible power output of a wind turbine. A series of performance data samples is acquired. Each performance data sample includes a meteorological condition and a power output indicated at a first time by one or more sensors associated with a wind turbine. A transfer function is calculated based at least in part on the series of performance data samples. The transfer function relates power output to the meteorological condition.

Abstract: A multi layer interconnecting substrate has at least two spaced apart metal layers with a conductive pad on each one of the metal layers. Two different types of insulating layers are placed between the metal layers. The placement is such that one of the two different types of insulating layers is placed between the conductive pads and the other type of insulating layer is placed between the two spaced apart metal layers.

Abstract: Certain embodiments of the present invention provide a system for clinical review of a patient comprising: a plurality medical studies relating to a medical history of the patient, each of said plurality of medical studies comprising a representation; a user interface for permitting a user to interact with said representations; a chronology of said representations displayable through said user interface, wherein each of said representations is selectable by said user to form a selected chronological medical study; and a plurality of relevant representations displayable through said user interface, said plurality of relevant representations automatically generated based at least in part on said selected chronological medical study and at least one relevance criterion, wherein each of said plurality of relevant representations is selectable to form a selected relevant medical study.

Abstract: The invention provides a system and method for storing a copy of data stored in an information store. In one embodiment, a data agent reads one or more blocks containing the data from the information store. The data agent maps the one or more blocks to provide a mapping of the blocks, and transmits the one or more blocks and mapping to a media agent for a storage device. The media agent stores the one or more blocks in the storage device according to the mapping.

Abstract: A slew rate improved operational amplifier circuit is provided to improve the slew rates of an operational amplifier with minimal sacrifices in power dissipation and other operational amplifier parameters. To improve the slew rates of operational amplifiers, additional current sources are activated when a slewing operation is detected. The detection of slewing operations and the activation of current sources upon detection can be implemented using two comparator circuits—one for a positive slewing operation, and one for a negative slewing operation. A sub-45 nm FinFET implementation of this slew rate improvement concept was implemented and compared against slew rate optimized individual two-stage operational amplifiers. Simulations show that slew rates were significantly improved by the implementation of the comparator circuits (5590 V/?s vs. 273 V/?s), with minimal increases in power dissipation (78 ?W vs. 46 ?W).

Abstract: A compound, composition and method of making and using a compound of formula 1 are disclosed. The compound of formula I also comprises of salts, polymorphs, solvates, mesylates, hydrochloric salt, solvates and hydrates thereof. The compound may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for peroral, topical, transmucosal, inhalation, targeted delivery and sustained release formulations. Such compositions may be used to treat metal accumulation in blood, organs and due to genetic complications.

Abstract: A compound, composition, method of synthesizing and using the compound of formula 1 are disclosed. The compound of formula I also comprises of salts, polymorphs, solvates, and hydrates thereof. The compound may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for peroral, topical, transmucosal, inhalation, targeted delivery and sustained release formulations. Such compositions may be used to treat hepatic and genetic disorders related to copper overload. Multiple other compounds may be added with the instant claimed compounds and may be delivered as a pharmaceutical dose suitable for treating Wilson's disease.

Abstract: A system and method using both static and transient modeling of power cables coupled with real time measurements of distributed temperature profiles of both the cable and it's immediate environment to optimize the current loads of the power cable. The optical fibers used for measuring distributed temperature profiles can be integrated directly into the monitored power cables or be deployed alongside the power cables, including using the optical fibers deployed in optical power ground wire systems.

Abstract: A compound, composition and method of making and using a compound of formula 1 are disclosed. The compound of formula I also comprises of salts, polymorphs, solvates, mesylates, hydrochloric salt, solvates and hydrates thereof. The compound may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for peroral, topical, transmucosal, inhalation, targeted delivery and sustained release formulations. Such compositions may be used to treat metal accumulation in blood, organs and due to genetic complications.

Abstract: A compound, composition, method of synthesizing and using the compound of formula 1 are disclosed. The compound of formula I also comprises of salts, polymorphs, solvates, and hydrates thereof. The compound may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for peroral, topical, transmucosal, inhalation, targeted delivery and sustained release formulations. Such compositions may be used to treat hepatic and genetic disorders related to copper overload.

Abstract: The present invention relates to the field of corrosion inhibition in hydrocarbon fluid processing units. The present invention comprises a new additive for inhibiting acid corrosion comprising polymeric thiophosphate ester, which is obtained by reaction of a polymer compound having mono, di or poly hydroxyl group, preferably polymer compound which is hydroxyl-termination, more preferably said polymer compound comprising hydroxyl-terminated polyisobutylene or polybutene and phosphorous pentasulphide. Said polymeric thiophosphate ester is further reacted with any oxide selected from group consisting of ethylene oxide, butylenes oxide or propylene oxide or such other oxide, preferably ethylene oxide, capably forming ethylene oxide derivative of thiophosphate ester. The invention is useful effecting acid corrosion inhibition on the metal surfaces of a distillation unit, distillation column, trays, packing and pump around piping.